| |
| |
|
| Insider
Information: |
Paster Anne-Mari |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
8,417,157 |
|
|
Indirect Shares
|
693,272 |
|
|
| Direct
Value |
$32,999,127 |
|
|
|
Indirect Value
|
$569,176 |
|
|
| Total
Shares |
9,110,429 |
|
|
| Total
Value |
$33,568,303 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kezar Life Sciences, Inc. |
KZR |
Former 10% Owner |
2018-06-25 |
693,272 |
2018-06-25 |
693,272 |
Premium* |
|
|
Replimune Group Inc |
REPL |
10% Owner |
2018-07-24 |
4,854,783 |
2018-07-24 |
0 |
Premium* |
|
|
Theseus Pharmaceuticals, Inc. |
THRX |
Former 10% owner |
2021-10-12 |
711,479 |
2021-10-12 |
0 |
Premium* |
|
|
Lexeo Therapeutics, Inc. |
LXEO |
10% Owner |
2023-11-07 |
2,157,623 |
2023-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
8 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,703,078 |
1,703,078 |
0 |
- |
|
| LXEO |
Lexeo Therapeutics, Inc. |
10% Owner |
– – • |
2023-11-07 |
4 |
B |
$11.00 |
$4,999,995 |
D/D |
454,545 |
2,157,623 |
2.45 |
- |
|
| THRX |
Theseus Pharmaceuticals, ... |
Former 10% owner |
– – – |
2021-10-12 |
4 |
A |
$0.00 |
$0 |
D/D |
523,979 |
523,979 |
0 |
- |
|
| THRX |
Theseus Pharmaceuticals, ... |
Former 10% owner |
– – – |
2021-10-12 |
4 |
B |
$16.00 |
$3,000,000 |
D/D |
187,500 |
711,479 |
2.44 |
- |
|
| REPL |
Replimune Group Inc |
10% Owner |
– – • |
2018-07-24 |
4 |
B |
$15.00 |
$4,000,005 |
D/D |
266,667 |
266,667 |
2.45 |
- |
|
| REPL |
Replimune Group Inc |
10% Owner |
– – • |
2018-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,588,116 |
4,854,783 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
Former 10% Owner |
– – – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
693,272 |
693,272 |
0 |
- |
|
| KZR |
Kezar Life Sciences, Inc. |
Former 10% Owner |
– – – |
2018-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
693,272 |
693,272 |
0 |
- |
|
8 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
